Showing results (2281-2290 of 2,475) with videos related to
Sort By:
Pageof 248
American Journal of Cancer Research|August 6, 2021
Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancerMasanori Oshi, Tsutomu Kawaguchi, Li Yan, et al.European Urology Open Science|December 10, 2020
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular SubtypesSalma Ben-Salem, Qiang Hu, Yang Liu, et al.Physical Review Letters|June 12, 2026
Quantum-Enhanced Sensing Enabled by Scrambling-Induced Genuine Multipartite EntanglementGuantian Hu, Wenxuan Zhang, Zhihua Chen, et al.Cell Reports|July 17, 2026
Deep learning reveals FLAD1-mediated mitochondrial metabolic reprogramming in hypoxic tumorsXiangyu Zhao, Tao Wu, Sanan Wu, et al.JAMA Oncology|November 11, 2016
Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways StudySong Yao, Marilyn L Kwan, Isaac J Ergas, et al.Acta Pharmacologica Sinica|March 1, 2022
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancersJiang-Yan Cao, Shuang Qi, Hong Wu, et al.Nature Communications|July 2, 2025
Deterministic switching of antiferromagnetic spin textures by nonlinear magnonsJilei Chen, Mingran Xu, Jinlong Wang, et al.Blood|April 14, 2007
Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblastic island formation in mouse fetal liverXue-Song Liu, Xi-Hua Li, Yi Wang, et al.Oncotarget|July 23, 2014
Circulating miR-148b and miR-133a as biomarkers for breast cancer detectionJie Shen, Qiang Hu, Michael Schrauder, et al.Science Advances|May 8, 2021
Programmable Bloch polaritons in grapheneLin Xiong, Yutao Li, Minwoo Jung, et al.Pageof 248